Ulcerative colitis Trials in Wrocław, Poland
Conditions / Ulcerative colitis / Wrocław, Poland
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
98 total trials for this combination
Showing top 10 of 98 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT05507203 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | COMPLETED | PHASE3 |
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT02435992 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT04033445 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | COMPLETED | PHASE3 |